OHSU’s Center for Regenerative Medicine, led by Kenton Gregory, M.D., has just received funding as part of the second phase of the Armed Forces Institute of Regenerative Medicine (AFIRM), a five-year, $75 million consortium led by Wake Forest Baptist Medical Center that will focus on applying regenerative medicine to battflefield injuries.
OHSU–one of 30 academic and industry partners in the consortium–will receive $1.5 million to manage the limb injury program and perform a clinical trial to restore extremely injured limbs in soldiers that would likely otherwise be permanently disabled. According to Dr. Gregory, it’s the first time this kind of trial will be performed in humans.
AFIRM-II is funded by the U.S. Army Medical Research and Materiel Command, the Office of Naval Research, the Air Force Medical Service, the Office of Research and Development – Department of Veterans Affairs, the National Institutes of Health, and the Office of the Assistant Secretary of Defense for Health Affairs.
Read the AFIRM-II press release to learn more.